Heritage Cannabis Holding Corp (HERTF)
0.0022
0.00 (0.00%)
USD |
OTCM |
May 10, 16:00
Heritage Cannabis Enterprise Value: 3.877M for May 10, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 10, 2024 | 3.877M |
| May 09, 2024 | 3.877M |
| May 08, 2024 | 3.783M |
| May 07, 2024 | 3.972M |
| May 06, 2024 | 3.688M |
| May 03, 2024 | 3.310M |
| May 02, 2024 | 3.310M |
| May 01, 2024 | 3.310M |
| April 30, 2024 | 3.499M |
| April 29, 2024 | 3.216M |
| April 26, 2024 | 3.216M |
| April 25, 2024 | 2.743M |
| April 24, 2024 | 2.743M |
| April 23, 2024 | 2.743M |
| April 22, 2024 | 2.743M |
| April 19, 2024 | 2.743M |
| April 18, 2024 | 2.743M |
| April 17, 2024 | 3.216M |
| April 16, 2024 | 3.499M |
| April 15, 2024 | 3.121M |
| April 12, 2024 | 3.121M |
| April 11, 2024 | 3.121M |
| April 10, 2024 | 3.121M |
| April 09, 2024 | 2.743M |
| April 08, 2024 | 3.688M |
| Date | Value |
|---|---|
| April 05, 2024 | 3.688M |
| April 04, 2024 | 4.633M |
| April 03, 2024 | 4.350M |
| April 02, 2024 | 13.14M |
| April 01, 2024 | 9.972M |
| March 28, 2024 | 8.979M |
| March 27, 2024 | 8.412M |
| March 26, 2024 | 8.224M |
| March 25, 2024 | 8.034M |
| March 22, 2024 | 6.995M |
| March 21, 2024 | 8.507M |
| March 20, 2024 | 8.224M |
| March 19, 2024 | 5.578M |
| March 18, 2024 | 7.978M |
| March 15, 2024 | 6.523M |
| March 14, 2024 | 6.759M |
| March 13, 2024 | 6.995M |
| March 12, 2024 | 6.334M |
| March 11, 2024 | 7.468M |
| March 08, 2024 | 6.428M |
| March 07, 2024 | 7.468M |
| March 06, 2024 | 7.732M |
| March 05, 2024 | 7.326M |
| March 04, 2024 | 6.428M |
| March 01, 2024 | 6.428M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
2.743M
Minimum
Apr 09 2024
183.25M
Maximum
Jul 23 2019
49.63M
Average
45.23M
Median
Dec 01 2020
Enterprise Value Benchmarks
| Acasti Pharma Inc | 0.8283M |
| Aurinia Pharmaceuticals Inc | 367.47M |
| Edesa Biotech Inc | 10.35M |
| Lexaria Bioscience Corp | 40.58M |
| Xenon Pharmaceuticals Inc | 2.421B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -10.28M |
| Revenue (Quarterly) | 5.873M |
| Total Expenses (Quarterly) | 7.861M |
| EPS Diluted (Quarterly) | -0.0074 |
| Gross Profit Margin (Quarterly) | 38.89% |
| Profit Margin (Quarterly) | -175.1% |
| Earnings Yield | -557.1% |
| Normalized Earnings Yield | -182.55 |